These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21853546)

  • 1. Clinical laboratory as an economic model for business performance analysis.
    Buljanović V; Patajac H; Petrovecki M
    Croat Med J; 2011 Aug; 52(4):513-9. PubMed ID: 21853546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing and using a balanced scorecard: a case study with SWOT analysis.
    Gumbus A; Lussier RN
    Clin Leadersh Manag Rev; 2003; 17(2):69-74. PubMed ID: 12701559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Strengths, Weaknesses, Opportunities, and Threats as a Tool for Translating Evidence into Individualized Medical Strategies (I-SWOT).
    von Kodolitsch Y; Bernhardt AM; Robinson PN; Kölbel T; Reichenspurner H; Debus S; Detter C
    Aorta (Stamford); 2015 Jun; 3(3):98-107. PubMed ID: 27069939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Universal Health Coverage in Iran: A Review of Strengths, Weaknesses, Opportunities, and Threats.
    Askarzade E; Nabizade Z; Goharinezhad S; Mostaghim S
    Med J Islam Repub Iran; 2023; 37():6. PubMed ID: 37123342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intellectual property management at the National Animal Science Research Institute in India: A case study.
    Chandrasekharan CC; Jiji RS
    Vet World; 2019 Jul; 12(7):1070-1077. PubMed ID: 31528035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strengths, Weaknesses, Opportunities, and Threats (SWOT) Analysis of Hemodialysis Electronic Health Record Implementation.
    Bennis B; El Bardai G; Chouhani BA; Kabbali N; Sqalli T
    Cureus; 2024 Feb; 16(2):e54675. PubMed ID: 38523930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis social clubs in Belgium: organizational strengths and weaknesses, and threats to the model.
    Decorte T
    Int J Drug Policy; 2015 Feb; 26(2):122-30. PubMed ID: 25179934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronavirus disease-2019 risk management using strengths, weaknesses, opportunities, threats analysis approach in the health system: A qualitative multimethod study.
    Bazyar J; Alimoradi S; Seydi M; Pourvakhshoori N; Sadeghifar J
    J Educ Health Promot; 2021; 10():453. PubMed ID: 35233400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospital laboratories as profit centers.
    Gray SP; Steiner J
    Health Care Strateg Manage; 1988 Nov; 6(11):7-9. PubMed ID: 10302965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tips from the toolkit: 2--assessing organisational strengths.
    Steer N
    Aust Fam Physician; 2010 Mar; 39(3):168-9. PubMed ID: 20369123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Strengths-Weaknesses-Opportunities-Threats (SWOT) analysis on the clinical utility of sperm DNA fragmentation testing in specific male infertility scenarios.
    Esteves SC; Agarwal A; Cho CL; Majzoub A
    Transl Androl Urol; 2017 Sep; 6(Suppl 4):S734-S760. PubMed ID: 29082207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proof of profitability. University medical center increase laboratory revenue and improves operational processes with outreach services.
    Catarella GV
    Health Manag Technol; 2004 Mar; 25(3):32-5. PubMed ID: 14997731
    [No Abstract]   [Full Text] [Related]  

  • 13. Costs, commitment and locality: a comparison of for-profit and not-for-profit health plans.
    Inquiry; 2004; 41(2):116-29. PubMed ID: 15449428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. THE STRENGTHS, WEAKNESSES, OPPORTUNITIES, AND THREATS (SWOTs) ANALYSES OF THE EBOLA VIRUS - PAPER RETRACTED.
    Babalola MO
    Afr J Infect Dis; 2016; 10(2):69-88. PubMed ID: 28480441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The profit potential of hospital labs.
    Serb C
    Hosp Health Netw; 2008 Jan; 82(1):46-8, 2. PubMed ID: 18286897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benchmarking hospital laboratory financial and operational performance.
    Portugal B
    Hosp Technol Ser; 1993 Dec; 12(17):1-21. PubMed ID: 10171737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development opportunities for hospital clinical laboratory joint ventures.
    Van Riper JA
    Clin Lab Manage Rev; 1995; 9(2):83-6. PubMed ID: 10141699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Business planning: a template for success.
    Dye J
    Clin Leadersh Manag Rev; 2002; 16(1):39-43. PubMed ID: 11828789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The new leader's guide to diagnosing the business.
    Gottfredson M; Schaubert S; Saenz H
    Harv Bus Rev; 2008 Feb; 86(2):62-73, 135. PubMed ID: 18314634
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.